Literature DB >> 17197717

To close or not to close: PFO, sex and cerebrovascular events.

Toby Ferguson1, Lauren H Sansing, Howard Herrmann, Brett Cucchiara.   

Abstract

We report on 2 patients with cerebrovascular events associated with sexual activity and PFO who subsequently underwent endovascular patent foramen ovale (PFO) closure. The concurrence of sexual activity (a Valsalva equivalent) at symptom onset, together with supporting data, prior paradoxical embolus in 1 case, elevated D-dimer in another, supported paradoxical embolization as the most likely mechanism of the cerebrovascular events. These cases emphasize that clinicians evaluating patients for PFO closure should explicitly inquire about sexual activity at stroke onset.

Entities:  

Mesh:

Year:  2006        PMID: 17197717

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  3 in total

1.  Heart-brain signaling in patent foramen ovale-related stroke: differential plasma proteomic expression patterns revealed with a 2-pass liquid chromatography-tandem mass spectrometry discovery workflow.

Authors:  Mary F Lopez; David A Sarracino; Maryann Vogelsang; Jennifer N Sutton; Michael Athanas; Bryan Krastins; Alejandra Garces; Amol Prakash; Scott Peterman; Zareh Demirjian; Ignacio Inglessis-Azuaje; Kathleen Feeney; Mikaela Elia; David McMullin; G William Dec; Igor Palacios; Eng H Lo; Ferdinand Buonanno; MingMing Ning
Journal:  J Investig Med       Date:  2012-12       Impact factor: 2.895

Review 2.  The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease.

Authors:  Mingming Ning; Eng H Lo; Pei-Chen Ning; Su-Yu Xu; David McMullin; Zareh Demirjian; Ignacio Inglessis; G William Dec; Igor Palacios; Ferdinando S Buonanno
Journal:  Pharmacol Ther       Date:  2013-03-23       Impact factor: 12.310

Review 3.  Pharmaco-proteomics opportunities for individualizing neurovascular treatment.

Authors:  M M Ning; M Lopez; D Sarracino; J Cao; M Karchin; D McMullin; X Wang; F S Buonanno; E H Lo
Journal:  Neurol Res       Date:  2013-06       Impact factor: 2.448

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.